Wireless handsets developer InfoSonics Corporation (NASDAQ:IFON) exploded nearly 40% on Monday, despite the absence of company news. InfoSonics Corporation (NASDAQ:IFON) stock opened at $2.17 in last session, and closed at $2.92, while the day range of stock is $2.10 – $3.08. The stock showed a positive weekly performance of 93.38%.
ProPhase Labs, Inc. (Nasdaq: PRPH) 31.3% HIGHER; no news out directly on the stock, though another blast of frigid air hitting much of the U.S. might be good for its Cold-EEZE business. ProPhase Labs Inc (NASDAQ:PRPH) stock opened at $2.10, in last session and closed at $2.25, by gaining 27.84%. The 52 week range of the stock is $1.35 – $2.98. Company’s market capitalization is $35.74 million.
Shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) were up more than 25% yesterday, ahead of the company’s report of phase 2 results for its oral insulin drug 0801 on Jan. 30. For diabetes-drug makers, oral insulin has long been a holy grail, and if these trial results are strong, the company will probably have no problem finding a partner, if not a buyer. Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) stock advanced 21.90% and finished the last session at $24.38. The EPS of the stock remained -0.59. Company’s market capitalization is $237.59 million.
The shares of QC Holdings, Inc. (NASDAQ:QCCO) trade at a substantial discount to its peers and at a price-to-tangible book value multiple of 0.61. This is partly due to the temporary removal of the quarterly dividend, due to a prohibition by the amendment that the company entered into with its lenders following the company’s failure to comply with a financial EBITDA covenant. QC Holdings, Inc. (NASDAQ:QCCO) stock opened the session at $1.99, and closed the session at $2.29. The 52 week range of the stock remained $1.61 – $3.64 and the day range was $1.93 – $2.29.